BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:10 PM
Aug 02, 2007
 |  BC Extra  |  Top Story

Pharmion jumps on MDS data

PHRM gained $14.39 (58%) to $39.03 after reporting that Vidaza azacitidine plus best supportive care met the primary endpoint of a significant improvement in survival vs. conventional care regimens in a Phase III...

Read the full 147 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >